Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CACNA1D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DFFB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | RP11-201K10.3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CHRNA7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | PPARA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | KRTAP5-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DPF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | CD96 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PKM | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | CCNJ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |